Partner Content Partner Content Only four weeks left until the 2nd Injectable Drug Delivery ... The 2019 agenda features a global panel of speakers
Partner Content Partner Content Regulatory Guidance for Microbiome-Based Therapeutics Join The Microbiome Movement
Partner Content Partner Content UserWise to lead a post-conference workshop at Pre-Filled Sy... Pre-Filled Syringes West Coast 2019
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
